Short- and potential long-term adverse health outcomes of COVID-19: a rapid reviewMiriam T Y Leung, Ian Chi Kei Wong, M. S. M. Ip et al.|Emerging Microbes & Infections|2020Cited by 240
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Marc A. Suchard, Michael B. Cook et al.|BMJ Medicine|2023Cited by 27
Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018Min Fan, Xue Li, Eric Yuk Fai Wan et al.|Orphanet Journal of Rare Diseases|2022Cited by 9